Anna David (University College London, UK) discusses her research into the development of new treatments for fetal growth restriction using maternal gene therapy.
Filmed at this year’s American Association of Pharmaceutical Scientists’ (AAPS) workshop on Opportunities and Challenges in Translating Cell and Gene Therapy Products (4—5 September; London, UK), we spoke to Anna David (University College London, UK) to look behind her lecture.
In the interview, she discusses the challenges of administering a fetal gene therapy, her experiences working with the UK regulators and more.
Find out more in these top picks from the Editor:
- CRISPR scientist claims to have made the world’s first gene edited babies
- Neonatal surgery, teaching and research: an interview with Diana L Farmer
- ISSCR issues statement opposing restriction of fetal tissue research